Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Current Deferred Tax Assets (2010 - 2011)

Updated

Biogen (BIIB) posted Current Deferred Tax Assets of $8.1 million for Q4 2011, down 92.8% from $112.2 million a year earlier.

Analysis

Biogen (BIIB) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

  • In prior years, Biogen's Current Deferred Tax Assets was $112.2 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.40 Bn 1,112.99 Bn 19.71 Bn
2 Johnson & Johnson 634.88 Bn 554.74 Bn 17.30 Bn
3 AbbVie 500.40 Bn 473.51 Bn 12.70 Bn
4 Merck 356.05 Bn 310.43 Bn 12.21 Bn
5 Novartis Ag 301.50 Bn 265.49 Bn 11.24 Bn
6 Astrazeneca 264.72 Bn 238.40 Bn 12.86 Bn
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn
8 Gilead Sciences 195.19 Bn 169.39 Bn 6.22 Bn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn
10 Biogen 36.63 Bn 23.28 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 8.10 Mn
Dec 31, 2010 112.20 Mn
API Access

Biogen Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEY